🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 4

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 4 of 20
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Mar 10, 2024 at 12:16 AM#16
SleepDoc_PDX said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

Same pattern here, and in the same order. The detail I would add is minor and it is already implied above.

2 0mike_mod, SarahChen_PharmD
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Mar 11, 2024 at 11:24 PM#17
hank_denver said:
TrialTracker_MD said: ...regarding the trial evidence...

Adding the part of the answer the thread has not reached. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

3 1JessicaH_TX, KevinCompounds, TirzTom
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 13, 2024 at 10:31 PM#18

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

4 2mel_PDX, Dr.AddMedPHL, newstart_MO and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SkepticalSean
Member
98
345
Jan 2025
Maine
Mar 15, 2024 at 9:37 PM#19

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

Last edited: Mar 16, 2024 at 1:37 AM
5 3tammy_FL, Dr.LipidDallas, alex_tucson and 2 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 17, 2024 at 8:42 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. No action needed from anybody.

Last edited: Mar 18, 2024 at 12:42 AM
27 0PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 24 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register